Short communication
C-ANCA positive necrotising scleritis and multiple sclerosis compatible with ocular Wegener: Treatment with rituximab
Escleritis necrotizante c-ANCA positivo y esclerosis múltiple compatible con Wegener ocular: tratamiento con rituximab
V. Aldasoro-Cáceresa,
, I. Aldasoro-Cáceresb, J.V. Pérez-Moreirasc, M. Murié-Fernándeza, R. Ibáñez-Boschd
Corresponding author
a Sección de Reumatología, Clínica Universidad de Navarra, Pamplona, Spain
b Servicio de Oftalmología, Hospital Universitario de Cruces, Bilbao, Bizkaia, Spain
c Servicio de Neurología, Clínica Oftalmológica Moreiras, A Coruña, Spain
d Unidad de Reumatología, Complejo Hospitalario de Navarra, Pamplona, Spain
Read
2175
Timeswas read the article
265
Total PDF
1910
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2023 3 | 2 | 0 | 2 |
| 2018 2 | 12 | 1 | 13 |
| 2018 1 | 27 | 1 | 28 |
| 2017 12 | 14 | 0 | 14 |
| 2017 11 | 27 | 1 | 28 |
| 2017 10 | 26 | 0 | 26 |
| 2017 9 | 20 | 8 | 28 |
| 2017 8 | 32 | 4 | 36 |
| 2017 7 | 40 | 1 | 41 |
| 2017 6 | 41 | 3 | 44 |
| 2017 5 | 43 | 2 | 45 |
| 2017 4 | 36 | 1 | 37 |
| 2017 3 | 34 | 15 | 49 |
| 2017 2 | 66 | 6 | 72 |
| 2017 1 | 68 | 2 | 70 |
| 2016 12 | 66 | 6 | 72 |
| 2016 11 | 71 | 6 | 77 |
| 2016 10 | 75 | 7 | 82 |
| 2016 9 | 59 | 4 | 63 |
| 2016 8 | 62 | 2 | 64 |
| 2016 7 | 42 | 3 | 45 |
| 2016 6 | 43 | 5 | 48 |
| 2016 5 | 42 | 9 | 51 |
| 2016 4 | 55 | 13 | 68 |
| 2016 3 | 35 | 11 | 46 |
| 2016 2 | 64 | 10 | 74 |
| 2016 1 | 47 | 12 | 59 |
| 2015 12 | 40 | 13 | 53 |
| 2015 11 | 31 | 12 | 43 |
| 2015 10 | 46 | 9 | 55 |
| 2015 9 | 40 | 6 | 46 |
| 2015 8 | 55 | 4 | 59 |
| 2015 7 | 80 | 12 | 92 |
| 2015 6 | 36 | 3 | 39 |
| 2015 5 | 37 | 3 | 40 |
| 2015 4 | 42 | 9 | 51 |
| 2015 3 | 85 | 4 | 89 |
| 2015 2 | 27 | 5 | 32 |
| 2015 1 | 29 | 4 | 33 |
| 2014 12 | 19 | 7 | 26 |
| 2014 11 | 29 | 2 | 31 |
| 2014 10 | 29 | 9 | 38 |
| 2014 9 | 57 | 11 | 68 |
| 2014 8 | 33 | 6 | 39 |
| 2014 7 | 46 | 13 | 59 |
Show all
